Transaction · 0001104659-26-103374

Culverwell Anthony James

Culverwell Anthony James, DIR, reported a transaction classified as grant at Quoin Pharmaceuticals, Ltd. involving 31352.000000 shares for an estimated $161462.80. Reported holdings after the transaction were 34218.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
QNRXQuoin Pharmaceuticals, Ltd.
Filing timeAug 28
Trade dateAug 27, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

QNRX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
QNRX since 2026-08-28Filed 6 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001104659-26-103374
ADSs
Transaction date
Aug 27, 2026
Filed Aug 28, 2026, 10:39 PM · 1d delay
Shares
31.3k sh
$515 per share
Estimated value
$16.1M
Computed from shares × price
Holdings after
34.2k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Increase
-12score
Filing-only score

-12

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Ordinary Shares are represented by American Depositary Shares ("ADSs"). Each ADS represents thirty-five (35) ordinary shares of the Issuer.

  2. F2

    On August 27, 2026, the Issuer and the Reporting Person, entered into an exchange agreement, pursuant to which $161,461 of accrued interest outstanding ("Outstanding Debt") owed in connection with a n…

Original filing · 0001104659-26-103374
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

QNRX